Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair loss may indicate higher heart risk and metabolic issues.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Various treatments exist for hair loss, but more research is needed for better options.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

PRP injections improve hair density in male hair loss.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Almost 40% of women aged 20-70 in Isfahan had hair loss, with it being more severe in those with low ferritin levels.

Traditional Chinese medicine techniques like catgut embedment, moxibustion, and bloodletting showed better results for treating hair loss than the drug finasteride.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Low-level laser therapy is about 80% effective in treating hair loss, with best results in males, those who use it for over a year, and those with scalp conditions like dandruff and rash.

Regular aerobic exercise for over 60 minutes can delay and improve androgenic alopecia symptoms.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.